PHIA Koninklijke Philips N.V.

Philips recognized as top innovator for 10th consecutive year

Philips recognized as top innovator for 10th consecutive year

February 16, 2023

Company once again on Clarivate Top 100 Global Innovator list for consistent high performance and scale in innovativeness

Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, has once again been recognized as a Clarivate Top 100 Global Innovator™ in Clarivate Analytics’ 2023 list, which measures excellence focused on consistency and scale in innovativeness [1], thanks to its constant high performance on these metrics. Philips has now been included in this reputable list for 10 consecutive years.

“Our innovations empower people to take care of their health and well-being and help doctors and nurses to provide better, more sustainable and more convenient care,” said Roy Jakobs, CEO of Royal Philips. “It’s a great honor to be recognized as a Top 100 Global Innovator for the 10th consecutive year, along with so many esteemed companies. Building on our more than 130 years of delivering meaningful innovation, we will continue to innovate with great passion, with our goal to improve 2.5 billion lives a year by 2030.”

Philips is one of the world's leading innovators in health technology, investing more than EUR 1.7 billion annually in research and development to deliver patient- and people-centric innovation. With its global presence, strong informatics platforms, ambulatory monitoring and imaging data, and personal health offerings, as well as strong capabilities to support care across settings, Philips is well positioned to help improve people’s health and healthcare outcomes, and make care more convenient and sustainable, both in the hospital and at home.

In the consumer domain, Philips develops innovative solutions that support healthier lifestyles, prevent disease, and help people to live well with chronic illness, also in the home and community settings. In clinics and hospitals, Philips cooperates closely with healthcare providers to innovate and transform the way care is delivered. This includes flagship innovations such as:

  • , leveraging a breakthrough design where the magnetic components are completely sealed and only need seven liters of helium over its lifetime compared to roughly 1,500 liters with other systems. Additionally, it uses up to 53% less power per patient;
  • , supporting less invasive procedures and helping physicians deliver better patient care by combining clinical excellence with workflow automation, resulting in 17% time saving per procedure;
  • , leveraging superior hardware and predictive AI-based software and services that together monitor patients throughout their hospital stay;
  • , the most advanced AI-supported electric toothbrush for personalized oral care. It senses pressure, motion, tooth coverage, and other brushing actions, and then automatically adapts in real time to those consumer behaviors. 

The full Top 100 Global Innovators 2023 report and full list can be found .

[1]    The Top 100 Global Innovators uses a complete comparative analysis of global invention data to assess the strength of every patented idea, using measures tied directly to their innovative power. To move from the individual idea strength to identify the organizations that create them more consistently and frequently, Clarivate sets two threshold criteria that potential candidates must meet and then adds a measure of their patented innovation output over the past five years. For full information on the methodology used to identify the 2023 list, see .

For further information, please contact:

Ben Zwirs

Philips Global Press Office

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
16/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips launches RADIQAL study to generate real-world evidence for new...

Philips launches RADIQAL study to generate real-world evidence for new ultra-low X-ray dose technology in coronary procedures May 20, 2025 Prospective, randomized, unblinded, comparative, international, multi-center clinical investigation824 patients across 6 hospitals in Spain, Czech Republic, Denmark and the USPrimary objective is to demonstrate that the new technology can reduce overall patient radiation dose without affecting coronary procedure performance. Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the (R...

 PRESS RELEASE

Philips launches real-time 3D intracardiac imaging in Europe, expandin...

Philips launches real-time 3D intracardiac imaging in Europe, expanding access to minimally invasive heart procedures May 19, 2025 VeriSight Pro 3D ICE catheter is a pioneering innovation — a miniaturized ultrasound probe embedded at the tip of a thin, steerable catheter, navigated through the vascular system into the heart chambers to deliver high-quality 2D and 3D images in real timeCatheter offers enhanced procedural guidance without the need for general anesthesia, supporting more efficient and patient-friendly care for structural heart disease Amsterdam, the Netherlands – (NYSE: PHG...

 PRESS RELEASE

Philips successfully prices offering of Notes for EUR 1 billion to be ...

Philips successfully prices offering of Notes for EUR 1 billion to be used for repayment of existing debt and to finance eligible green projects May 15, 2025 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the successful pricing of its offering of EUR 500 million fixed rate notes due 2030 and EUR 500 million fixed rate notes due 2035 (the “Notes”) under its European Medium Term Note (EMTN) program. The net proceeds will be used for general corporate purposes, the repayment of 2026 debt maturities, and to refinance or finance any ...

 PRESS RELEASE

Philips Future Health Index 2025: AI poised to transform global health...

Philips Future Health Index 2025: AI poised to transform global healthcare, urging leaders to act now May 15, 2025AI has the power to cut care delays and manage data overload, but trust gaps among clinicians and patients threaten to slow adoption and impactAmsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, , highlighting the growing strain on global healthcare systems. The FHI 2025 Report, the largest global survey of its kind analyzing key concerns of healthcare professionals and patients, indicates AI holds promise for transforming care delivery. H...

Koninklijke Philips N.V.: 1 director

A director at Koninklijke Philips N.V. bought 8,176 shares at 24.410USD and the significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two yea...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch